Author:
Hickson Sarah E.,Margineantu Daciana,Hockenbery David M.,Simon Julian A.,Geballe Adam P.
Funder
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Reference55 articles.
1. The unintended mitochondrial uncoupling effects of the FDA approved anti-helminth drug nitazoxanide mitigates experimental Parkinsonism in mice;Amireddy;J. Biol. Chem.,2017
2. Nitazoxanide, an antiviral thiazolide, depletes ATP-sensitive intracellular Ca(2+) stores;Ashiru;Virology,2014
3. Linking energy metabolism to dysfunctions in mitochondrial respiration--a metabolomics in vitro approach;Balcke;Toxicol. Lett.,2011
4. Bioavailability of two oral-suspension formulations of a single dose of nitazoxanide 500 mg: an open-label, randomized-sequence, two-period crossover, comparison in healthy fasted Mexican adult volunteers;Balderas-Acata;Bioequivalence Bioavailab.,2011
5. Reversal of the interferon-sensitive phenotype of a vaccinia virus lacking E3L by expression of the reovirus S4 gene;Beattie;J. Virol.,1995
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献